Application 021590

Type: NDA
Sponsor: JAZZ

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	FAZACLO ODT	CLOZAPINE	TABLET, ORALLY DISINTEGRATING;ORAL	25MG	Yes	No
002	FAZACLO ODT	CLOZAPINE	TABLET, ORALLY DISINTEGRATING;ORAL	100MG	Yes	No
003	FAZACLO ODT	CLOZAPINE	TABLET, ORALLY DISINTEGRATING;ORAL	50MG	No	No
004	FAZACLO ODT	CLOZAPINE	TABLET, ORALLY DISINTEGRATING;ORAL	12.5MG	Yes	No
005	FAZACLO ODT	CLOZAPINE	TABLET, ORALLY DISINTEGRATING;ORAL	150MG	Yes	No
006	FAZACLO ODT	CLOZAPINE	TABLET, ORALLY DISINTEGRATING;ORAL	200MG	Yes	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N021590-001	FAZACLO ODT	CLOZAPINE	25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2004-02-10
N021590-002	FAZACLO ODT	CLOZAPINE	100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2004-02-10
N021590-003	FAZACLO ODT	CLOZAPINE	50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2005-06-03
N021590-004	FAZACLO ODT	CLOZAPINE	12.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2007-05-30
N021590-005	FAZACLO ODT	CLOZAPINE	150MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2010-07-09
N021590-006	FAZACLO ODT	CLOZAPINE	200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2010-07-09

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 7 · 252 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N021590-001	FAZACLO ODT	25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2004-02-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021590-002	FAZACLO ODT	100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2004-02-10	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021590-003	FAZACLO ODT	50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2005-06-03	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021590-004	FAZACLO ODT	12.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2007-05-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021590-005	FAZACLO ODT	150MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2010-07-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021590-006	FAZACLO ODT	200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2010-07-09	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021590-001	FAZACLO ODT	25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2004-02-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021590-002	FAZACLO ODT	100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2004-02-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021590-003	FAZACLO ODT	50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2005-06-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021590-004	FAZACLO ODT	12.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2007-05-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021590-005	FAZACLO ODT	150MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2010-07-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021590-006	FAZACLO ODT	200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2010-07-09	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021590-001	FAZACLO ODT	25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2004-02-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021590-002	FAZACLO ODT	100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2004-02-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021590-003	FAZACLO ODT	50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2005-06-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021590-004	FAZACLO ODT	12.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2007-05-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021590-005	FAZACLO ODT	150MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2010-07-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021590-006	FAZACLO ODT	200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2010-07-09	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021590-001	FAZACLO ODT	25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2004-02-10	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021590-002	FAZACLO ODT	100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2004-02-10	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021590-003	FAZACLO ODT	50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		2005-06-03	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021590-004	FAZACLO ODT	12.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2007-05-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021590-005	FAZACLO ODT	150MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2010-07-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021590-006	FAZACLO ODT	200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2010-07-09	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021590-001	FAZACLO ODT	25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2004-02-10	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021590-002	FAZACLO ODT	100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2004-02-10	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021590-003	FAZACLO ODT	50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		2005-06-03	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021590-004	FAZACLO ODT	12.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2007-05-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021590-005	FAZACLO ODT	150MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2010-07-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021590-006	FAZACLO ODT	200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2010-07-09	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021590-001	FAZACLO ODT	25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2004-02-10	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021590-002	FAZACLO ODT	100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2004-02-10	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021590-003	FAZACLO ODT	50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		2005-06-03	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021590-004	FAZACLO ODT	12.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2007-05-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021590-005	FAZACLO ODT	150MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2010-07-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021590-006	FAZACLO ODT	200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2010-07-09	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021590-001	FAZACLO ODT	25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2004-02-10	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021590-002	FAZACLO ODT	100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2004-02-10	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021590-003	FAZACLO ODT	50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL		2005-06-03	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021590-004	FAZACLO ODT	12.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, ORALLY DISINTEGRATING / ORAL	RLD	2007-05-30	`03ed91905a0d…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N021590-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021590-002	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021590-004	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021590-005	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021590-006	AB	1	`74a2ff9319b5…`
2019-09-15 20:21 UTC	2019-09	N021590-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021590-002	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021590-004	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021590-005	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021590-006	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021590-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021590-002	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021590-004	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021590-005	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021590-006	AB	1	`ea99ee380514…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 16 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CLOZAPINE	CLOZAPINE	NorthStar Rx LLC	61fe53d5-ed5c-4e45-9189-709d08d386cb	2026-05-11	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: CLOZAPINE
CLOZAPINE	CLOZAPINE	Cardinal Health 107, LLC	7c748f8a-73ce-4bd3-aa30-9c66657f06ec	2026-04-21	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: CLOZAPINE
Clozapine	CLOZAPINE	Mylan Pharmaceuticals Inc.	883b5d43-0339-7dc1-f775-93791fb9b978	2026-04-15	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: CLOZAPINE
Clozapine	CLOZAPINE	Safecor Health, LLC	09231d80-6343-4a34-bd5b-100c547fd3c9	2026-03-13	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: CLOZAPINE
Clozapine	CLOZAPINE	Safecor Health LLC	0fa59238-f0a6-4d00-9d8d-df2a43718fc1	2026-03-09	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: CLOZAPINE
CLOZAPINE	CLOZAPINE	Major Pharmaceuticals	9db7aefb-f607-4158-a310-181e631bc648	2026-01-05	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: CLOZAPINE
CLOZAPINE	CLOZAPINE	Aurobindo Pharma Limited	5021d643-32d2-4167-b5d8-90870e68a787	2025-12-17	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: CLOZAPINE
Clozapine	CLOZAPINE	Mylan Institutional Inc.	d5c8a456-6f3c-4963-b321-4ed746f690e4	2025-11-11	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: CLOZAPINE
Clozapine	CLOZAPINE	Accord Healthcare Inc.	25c0c6d5-f7b0-48e4-e054-00144ff8d46c	2025-10-08	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: CLOZAPINE
Clozapine	CLOZAPINE	American Health Packaging	d36c298b-7292-46e0-898f-43d3e11c3cf4	2025-09-03	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: CLOZAPINE
Clozapine	CLOZAPINE	Mylan Pharmaceuticals Inc.	9ae4b8e4-d8b1-4f01-bb4c-cd1cea90b219	2025-08-15	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: CLOZAPINE
Clozapine	CLOZAPINE	Mylan Institutional Inc.	976be6e3-a9db-49c6-9b02-1ab168cf17b1	2025-07-18	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: CLOZAPINE
Clozapine	CLOZAPINE	Teva Pharmaceuticals USA, Inc.	6fccf4f7-2e30-4272-9800-225aaef20584	2025-06-24	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: CLOZAPINE
VERSACLOZ	CLOZAPINE	TruPharma LLC	2592c9a8-fd74-4e0d-a895-b07b014cf355	2025-06-23	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: CLOZAPINE
Clozaril	CLOZAPINE	HLS Therapeutics (USA), Inc.	90876802-0e3a-44c9-9ff7-1754dfbe736a	2025-06-06	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: CLOZAPINE
Clozapine	CLOZAPINE	Aurobindo Pharma Limited	caf2d4a6-2a23-4992-a807-560c4204afc4	2025-06-05	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: CLOZAPINE

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 23 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
0093-3010	Clozapine	clozapine	Teva Pharmaceuticals USA Inc	NDA AUTHORIZED GENERIC	Current
0093-3011	Clozapine	clozapine	Teva Pharmaceuticals USA Inc	NDA AUTHORIZED GENERIC	Current
0093-3012	Clozapine	clozapine	Teva Pharmaceuticals USA Inc	NDA AUTHORIZED GENERIC	Current
0093-3086	Clozapine	clozapine	Teva Pharmaceuticals USA Inc	NDA AUTHORIZED GENERIC	Current
0093-3086	Clozapine	clozapine	Teva Pharmaceuticals USA Inc	NDA AUTHORIZED GENERIC	Current
0093-3086	Clozapine	clozapine	Teva Pharmaceuticals USA Inc	NDA AUTHORIZED GENERIC	Current
0093-3086	Clozapine	clozapine	Teva Pharmaceuticals USA Inc	NDA AUTHORIZED GENERIC	Current
0093-3087	Clozapine	clozapine	Teva Pharmaceuticals USA Inc	NDA AUTHORIZED GENERIC	Current
0093-3087	Clozapine	clozapine	Teva Pharmaceuticals USA Inc	NDA AUTHORIZED GENERIC	Current
0093-3087	Clozapine	clozapine	Teva Pharmaceuticals USA Inc	NDA AUTHORIZED GENERIC	Current
0093-3087	Clozapine	clozapine	Teva Pharmaceuticals USA Inc	NDA AUTHORIZED GENERIC	Current
18860-101	FazaClo	clozapine	Jazz Pharmaceuticals, Inc.	NDA	Current
18860-101	FazaClo	clozapine	Jazz Pharmaceuticals, Inc.	NDA	Current
18860-101	FazaClo	clozapine	Jazz Pharmaceuticals, Inc.	NDA	Current
18860-102	FazaClo	clozapine	Jazz Pharmaceuticals, Inc.	NDA	Current
18860-102	FazaClo	clozapine	Jazz Pharmaceuticals, Inc.	NDA	Current
18860-104	FazaClo	clozapine	Jazz Pharmaceuticals, Inc.	NDA	Current
18860-104	FazaClo	clozapine	Jazz Pharmaceuticals, Inc.	NDA	Current
18860-104	FazaClo	clozapine	Jazz Pharmaceuticals, Inc.	NDA	Current
18860-105	FazaClo	clozapine	Jazz Pharmaceuticals, Inc.	NDA	Current
18860-105	FazaClo	clozapine	Jazz Pharmaceuticals, Inc.	NDA	Current
18860-106	FazaClo	clozapine	Jazz Pharmaceuticals, Inc.	NDA	Current
18860-106	FazaClo	clozapine	Jazz Pharmaceuticals, Inc.	NDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
62579	SUPPL	2020-04-15
62574	SUPPL	2020-04-15
57307	SUPPL	2019-01-22
47371	SUPPL	2017-03-02
47353	SUPPL	2017-02-27
37303	SUPPL	2015-10-22
28210	SUPPL	2015-10-02
37302	SUPPL	2015-09-16
37298	SUPPL	2015-09-16
28209	SUPPL	2015-09-16
28203	SUPPL	2015-09-16
24004	ORIG	2015-09-16
37301	SUPPL	2013-07-23
28207	SUPPL	2013-07-22
28208	SUPPL	2012-01-12
15843	SUPPL	2012-01-09
28206	SUPPL	2010-12-06
15842	SUPPL	2010-12-04
28205	SUPPL	2010-09-13
15841	SUPPL	2010-09-10
28204	SUPPL	2010-07-14
5812	SUPPL	2010-07-14
37300	SUPPL	2010-07-12
37299	SUPPL	2010-07-12
5811	SUPPL	2008-08-19
5810	SUPPL	2008-07-17
37297	SUPPL	2007-06-04
5809	SUPPL	2007-06-04
37296	SUPPL	2006-02-22
5808	SUPPL	2006-02-22
21751	ORIG	2005-10-06
28202	SUPPL	2005-08-16
15840	SUPPL	2005-08-15
5806	SUPPL	2005-08-15
37295	SUPPL	2005-06-10
5807	SUPPL	2005-06-10
28201	SUPPL	2004-09-07
28200	SUPPL	2004-06-23
15839	ORIG	2004-03-03
5805	ORIG	2004-02-27